Table 2.
Type | Advantages | Drawbacks | Source(s) |
---|---|---|---|
Aquatic models | |||
Planktonic crustaceans | Standardized protocols and guidelines; Easy implementation |
Primarily used as pre-screening method; Large biological difference to humans |
[98] |
Zebrafish | High throughput; Similar genome; Rapid developmental process; Low cost; Easy monitoring of embryogenesis; ADME effects studied |
Difficult monitoring of rapid developmental process; Ethical concerns; Species to species variation |
[100,101,104] |
Mammal models | |||
Small rodents | Multiple routes of exposure; Guidelines exist to evaluate nanotoxicity; ADME effects studied; Chronic effects studied |
Ethical concerns; Species to species variation; Expertise necessary; High cost |
[105,106] |